Hangzhou AGS Medtech Co (SHSE:688581) Risk Assessment

View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Hangzhou AGS Medtech Co is: No Data: Cannot be evaluated.

Competitive Comparison of Hangzhou AGS Medtech Co's Risk Assessment

For the Medical Devices subindustry, Hangzhou AGS Medtech Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou AGS Medtech Co's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Hangzhou AGS Medtech Co's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Hangzhou AGS Medtech Co (SHSE:688581) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Hangzhou AGS Medtech Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Hangzhou AGS Medtech Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou AGS Medtech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106

Website

http://www.bioags.com

Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.

Executives

Chen Jun Can	senior management
Li Peng	Core technical personnel
Han Chun Qi	Directors, senior managers, core technical personnel
Sheng Yue Yuan	Director
Zhang Qin Hua	senior management
Zhang Cheng	Director

Hangzhou AGS Medtech Co Headlines

No Headlines